期刊文献+

心脏磁共振心功能指标评估肺动脉高压患者预后的价值 被引量:8

Prognosis value of cardiac magnetic resonance cardiac function index in patients with pulmonary hypertension
下载PDF
导出
摘要 目的探讨心脏磁共振(CMR)成像指标与肺动脉高压(PH)患者预后的关系。方法纳入我院经右心导管插入确诊并行CMR检查的PH患者90例,分析其CMR图像并计算心功能指标:右心室和左心室舒张末期容积指数(EDVI)、收缩末期容积指数(ESVI)、每搏输出量指数(SVI)、射血分数(EF),以及右房室瓣环收缩期位移(TAPSE)。随访终点为发生主要心血管不良事件(MACE)。采用两独立样本t检验对发生MACE患者(MACE组)与未发生MACE患者(non-MACE组)的CMR指标进行比较。采用Cox比例风险回归模型分析终点事件的独立预测因素,根据受试者工作特征(ROC)曲线获得的最佳截断值绘制Kaplan-Meier生存曲线。结果与non-MACE组相比,MACE组患者右心室EF、左心室SVI、TAPSE均降低[(27.00±9.92)%vs(32.68±11.34)%、(29.14±8.73)m L/m2 vs(35.41±11.59)m L/m2、(12.51±4.17)mm vs(16.04±7.37)mm],右心室EDVI和ESVI均升高[(139.72±48.70)mL/m2vs(116.07±44.79)mL/m2、(104.26±42.88)mL/m2vs(79.37±35.67)mL/m2],差异均有统计学意义(t=-2.065、-2.286、-2.089、2.076、2.668,P均<0.05)。多因素分析结果显示,左心室SVI、TAPSE是PH患者发生MACE的独立预测因素[风险比(HR)=0.942、0.904,P=0.039、0.022]。ROC曲线确定的左心室SVI、TAPSE的最佳截断值分别为30.27 mL/m2、15.65 mm,Kaplan-Meier生存分析结果示当LVSVI≤30.27 mL/m2、TAPSE≤15.65 mm时MACE发生率增加(P=0.001、0.019)。结论发生MACE的PH患者左心、右心功能均较差,TAPSE、左心室SVI可作为PH患者发生MACE的独立预测因素。 Objective To explore the effect of cardiac magnetic resonance (CMR) imaging parameters on prognosis of the patients with pulmonary hypertension (PH). Methods Ninety PH patients, who were diagnosed by right heart catheterization and received CMR examination in our hospital, were enrolled for this study. The cardiac functional parameters, including end-diastolic volume index (EDVI), end-systolic volume index (ESVI), stroke volume index (SVI) and ejection fraction (EF) of the right ventricle and left ventricle, and tricuspid annular plane systolic excursion (TAPSE), were analyzed. The study end-point was major adverse cardiovascular event (MACE). Two independent sample t test was used to analyze the differences of CMR parameters between MACE group and non-MACE group. Cox proportional hazards regression model was used to determine the independent predictors of end-point events. Kaplan-Meier survival curve was drawn based on the optimal cut-off value of receiver operating characteristic (ROC) curve. Results Compared with the non-MACE group, the right ventricular EF, left ventricular SVI and TAPSE were decreased in the MACE group ([27.00±9.92]% vs [32.68±11.34]%,[29.14±8.73] mL/m^2 vs [35.41±11.59] mL/m^2 and [12.51±4.17] mm vs [16.04±7.37] mm), while the right ventricular EDVI and ESVI were increased ([139.72±48.70] mL/m^2 vs [116.07±44.79] mL/m^2 and [104.26±42.88] mL/m^2 vs [79.37±35.67] mL/m^2), and the differences were significant (t=-2.065,-2.286,-2.089, 2.076 and 2.668, all P<0.05). Multivariate analysis showed that left ventricular SVI and TAPSE were independent predictors of MACE in the PH patients (hazard ratio [HR]=0.942 and 0.904, P=0.039 and 0.022). The optimal cut-off values of left ventricular SVI and TAPSE determined by ROC curve were 30.27 mL/m^2 and 15.65 mm, respectively. Kaplan-Meier survival analysis showed that the incidence of MACE was significantly increased when left ventricular SVI≤30.27 mL/m^2 or TAPSE≤15.65 mm (P=0.001 and 0.019). Conclusion The left and right heart functions of PH patients with MACE are poor. TAPSE and left ventricular SVI are the independent predictors of MACE in the PH patients.
作者 任雯 张璋 杨帆 杨振文 李东 REN Wen;ZHANG Zhang;YANG Fan;YANG Zhen-wen;LI Dong(Department of Radiology,Tianjin Medical University General Hospital,Tianjin 300052,China;Department of Cardiovasology,Tianjin Medical University General Hospital,Tianjin 300052,China)
出处 《第二军医大学学报》 CAS CSCD 北大核心 2019年第3期262-269,共8页 Academic Journal of Second Military Medical University
基金 国家自然科学基金青年科学基金(81301217) 科技部"十三五"国家重点研发计划(2016YFC1300402) 天津市应用基础与前沿技术研究计划(14JCZDJC57000 18JCYBJC25100)~~
关键词 肺性高血压 磁共振成像 心脏功能 预后 pulmonary hypertension magnetic resonance imaging cardiac function prognosis
  • 相关文献

参考文献3

二级参考文献14

  • 1Paola Gargiulo,Fabio Marsico,Antonio Parente,Stefania Paolillo,Milena Cecere,Laura Casaretti,Angela Maria Pellegrino,Tiziana Formisano,Irma Fabiani,Andrea Soricelli,Bruno Trimarco,Pasquale Perrone-Filardi.Ischemic heart disease in systemic inflammatory diseases. An appraisal[J].International Journal of Cardiology.2014(3)
  • 2Gy?ngyvér K?lt?,Réka Faludi,Dániel Aradi,Barbara Bartos,Gábor Kumánovics,Tünde Minier,László Czirják,András Komócsi.Impact of cardiac involvement on the risk of mortality among patients with systemic sclerosis: a 5-year follow-up of a single-center cohort[J].Clinical Rheumatology.2014(2)
  • 3Maurizio Pieroni,Maria De Santis,Gaetano Zizzo,Silvia Bosello,Costantino Smaldone,Mara Campioni,Giacomo De Luca,Antonella Laria,Agostino Meduri,Fulvio Bellocci,Lorenzo Bonomo,Filippo Crea,Gianfranco Ferraccioli.Recognizing and Treating Myocarditis in Recent-Onset Systemic Sclerosis Heart Disease: Potential Utility of Immunosuppressive Therapy in Cardiac Damage Progression[J].Seminars in Arthritis and Rheumatism.2013
  • 4Stalin R Subramanian,Rakhshanda Akram,Arash Velayati,Hal Chadow.New development of cardiac tamponade on underlying effusive–constrictive pericarditis: an uncommon initial presentation of scleroderma[J].Case Reports (jul ).2013(jul122)
  • 5Robert Dinser,Marc Frerix,Florian M.P. Meier,Karin Klingel,Andreas Rolf.Endocardial and myocardial involvement in systemic sclerosis – is there a relevant inflammatory component?[J].Joint Bone Spine.2013(3)
  • 6Peter Kru?liak,Gabriela Ková?ová,?tefan Balogh.Pericardial effusion as a first sign of systemic scleroderma[J].Cor et Vasa.2012(4)
  • 7Udi Nussinovitch,Yehuda Shoenfeld.Atherosclerosis and macrovascular involvement in systemic sclerosis: Myth or reality[J].Autoimmunity Reviews.2010(5)
  • 8Sevdalina Lambova,Ulf Müller-Ladner.Pulmonary arterial hypertension in systemic sclerosis[J].Autoimmunity Reviews.2010(11)
  • 9Stephen C Mathai,Paul M Hassoun.Therapy for pulmonary arterial hypertension associated with systemic sclerosis[J].Current Opinion in Rheumatology.2009(6)
  • 10Vallerie V. McLaughlin,Stephen L. Archer,David B. Badesch,Robyn J. Barst,Harrison W. Farber,Jonathan R. Lindner,Michael A. Mathier,Michael D. McGoon,Myung H. Park,Robert S. Rosenson,Lewis J. Rubin,Victor F. Tapson,John Varga.ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension[J].Journal of the American College of Cardiology.2009(17)

共引文献8

同被引文献57

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部